Cargando…

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo

Neurofibrillary tangles (NFTs) are the pathological hallmark of neurodegenerative diseases commonly known as tauopathies. NFTs result from the intracellular aggregation of abnormally and hyperphosphorylated tau proteins. Tau functions, which include the regulation of microtubules dynamics, are depen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domise, Manon, Didier, Sébastien, Marinangeli, Claudia, Zhao, Haitian, Chandakkar, Pallavi, Buée, Luc, Viollet, Benoit, Davies, Peter, Marambaud, Philippe, Vingtdeux, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882625/ https://www.ncbi.nlm.nih.gov/pubmed/27230293 http://dx.doi.org/10.1038/srep26758

Ejemplares similares

AMP-activated Protein Kinase Controls Immediate Early Genes Expression Following Synaptic Activation Through the PKA/CREB Pathway
por: Didier, Sébastien, et al.
Publicado: (2018)

Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process
por: Domise, Manon, et al.
Publicado: (2019)

AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation
por: Marinangeli, Claudia, et al.
Publicado: (2018)

Effect of the CALHM1 G330D and R154H Human Variants on the Control of Cytosolic Ca(2+) and Aβ Levels
por: Vingtdeux, Valérie, et al.
Publicado: (2014)

Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
por: Koppel, Jeremy, et al.
Publicado: (2016)

Therapeutic potential of resveratrol in Alzheimer's disease
por: Vingtdeux, Valérie, et al.
Publicado: (2008)

CALHM1 deficiency impairs cerebral neuron activity and memory flexibility in mice
por: Vingtdeux, Valérie, et al.
Publicado: (2016)

Different tau species lead to heterogeneous tau pathology propagation and misfolding
por: Dujardin, Simon, et al.
Publicado: (2018)

MicroRNAs and the Regulation of Tau Metabolism
por: Hébert, Sébastien S., et al.
Publicado: (2012)

EuroTau: towing scientists to tau without tautology
por: Mudher, Amrit, et al.
Publicado: (2017)

Two-Dimensional Electrophoresis of Tau Mutants Reveals Specific Phosphorylation Pattern Likely Linked to Early Tau Conformational Changes
por: Bretteville, Alexis, et al.
Publicado: (2009)

Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models
por: Vitale, Francesca, et al.
Publicado: (2020)

Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
por: Faldini, Enrico, et al.
Publicado: (2019)

Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
por: Vitale, Francesca, et al.
Publicado: (2018)

Physiological and pathological phosphorylation of tau by Cdk5
por: Kimura, Taeko, et al.
Publicado: (2014)

Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
por: Vingtdeux, Valérie, et al.
Publicado: (2012)

Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies
por: Tardivel, Meryem, et al.
Publicado: (2016)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
por: Liao, Jung-Chi, et al.
Publicado: (2015)

A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10
por: Ruiz, Santiago, et al.
Publicado: (2016)

Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
por: Lam, Suzanne, et al.
Publicado: (2021)

The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology
por: Song, Liqing, et al.
Publicado: (2022)

Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
por: Albert, Marie, et al.
Publicado: (2019)

Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2018)

Calcium signaling in neurodegeneration
por: Marambaud, Philippe, et al.
Publicado: (2009)

Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy
por: Zheng, Jin, et al.
Publicado: (2020)

Passive immunization against phosphorylated tau improves features of Huntington's disease pathology
por: Alpaugh, Melanie, et al.
Publicado: (2022)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS
por: Moszczynski, Alexander J., et al.
Publicado: (2018)

What is the evidence that tau pathology spreads through prion-like propagation?
por: Mudher, Amrit, et al.
Publicado: (2017)

In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau
por: Zhang, Shengnan, et al.
Publicado: (2018)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation
por: Reimer, Lasse, et al.
Publicado: (2020)

The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
por: Sato, Naoyuki
Publicado: (2013)

Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2020)

Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases
por: Albayram, Onder, et al.
Publicado: (2018)

Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
por: Saura, Carlos A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjtm9rl8q264to040ifcoq0j4s